Corteria Pharmaceuticals is a startup based in Israel, 1 tracked investor.
Corteria Pharmaceuticals is a company founded in 2021 headquartered in Israel. Brouky records 1 investor associated with the company.
Corteria Pharmaceuticals is a privately held biotechnology company developing first-in-class drugs, focused on interceptive therapies for worsening and acute decompensated heart failure and related subpopulations such as sarcopenia and obesity. The company emphasizes innovative patient stratification and target selection to address high unmet medical needs in cardiovascular indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.